Marker Therapeutics Inc
NASDAQ:MRKR

Watchlist Manager
Marker Therapeutics Inc Logo
Marker Therapeutics Inc
NASDAQ:MRKR
Watchlist
Price: 1.28 USD 0.79% Market Closed
Market Cap: 21.3m USD

Wall Street
Price Targets

MRKR Price Targets Summary
Marker Therapeutics Inc

Wall Street analysts forecast MRKR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRKR is 8.33 USD with a low forecast of 4.04 USD and a high forecast of 13.13 USD.

Lowest
Price Target
4.04 USD
216% Upside
Average
Price Target
8.33 USD
551% Upside
Highest
Price Target
13.13 USD
925% Upside
Marker Therapeutics Inc Competitors:
Price Targets
9926
Akeso Inc
50% Upside
ALNY
Alnylam Pharmaceuticals Inc
26% Upside
AVCT
Avacta Group PLC
14% Upside
302440
SK Bioscience Co Ltd
23% Downside
RPTX
Repare Therapeutics Inc
40% Upside
688520
Sinocelltech Group Ltd
26% Upside
ADOC
Adocia SA
141% Upside
300896
Imeik Technology Development Co Ltd
40% Upside

Revenue
Forecast

Revenue Estimate
Marker Therapeutics Inc

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

N/A
Past Growth
109%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Marker Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRKR's stock price target?
Price Target
8.33 USD

According to Wall Street analysts, the average 1-year price target for MRKR is 8.33 USD with a low forecast of 4.04 USD and a high forecast of 13.13 USD.

What is Marker Therapeutics Inc's Revenue forecast?
Projected CAGR
109%

The compound annual growth rate of Marker Therapeutics Inc's revenue for the next 4 years is 109%.

Back to Top